Geographic Atrophy Secondary to AMD: Optimizing Patient Selection for Novel Therapeutics

Geographic Atrophy Secondary to AMD: Optimizing Patient Selection for Novel Therapeutics

In this CE activity, experts in the field review the latest understanding of the underlying mechanisms that lead to the development of GA secondary to AMD, evaluate the latest imaging technologies for the timely detection and monitoring of disease progression, and assess the latest evidence-based treatment protocols for the management of patients with GA.

  • Provider:Vindico Medical Education, LLC
  • Activity Link: https://www.healio.com/cme/retinacme/age-related-macular-degeneration/20241213/geographic-atrophy-secondary-to-amd-optimizing-patient-selection-for-novel-therapeutics/overview
  • Start Date: 2024-12-13 06:00:00
  • End Date: 2024-12-13 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
  • Commercial Support: Source: Astellas - Amount: 41500.0 - Is Kind Support: False Source: Topcon Healthcare, Inc. - Amount: 1822.5 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.